These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18165524)

  • 1. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt.
    El-Setouhy M; Abd Elaziz KM; Helmy H; Farid HA; Kamal HA; Ramzy RM; Shannon WD; Weil GJ
    Am J Trop Med Hyg; 2007 Dec; 77(6):1069-73. PubMed ID: 18165524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
    Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
    PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.
    Njenga SM; Kanyi H; Okoyo C; Githinji E; Mwatele C; Matendechero SH; Omondi WP; Gitahi PN; Owaga C; Onsongo JK; Gass K
    PLoS Negl Trop Dis; 2024 Jul; 18(7):e0011942. PubMed ID: 38976718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.
    Supali T; Djuardi Y; Lomiga A; Nur Linda S; Iskandar E; Goss CW; Miller JP; Weil GJ; Fischer PU
    Am J Trop Med Hyg; 2019 Feb; 100(2):336-343. PubMed ID: 30560772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
    Weil GJ; Kastens W; Susapu M; Laney SJ; Williams SA; King CL; Kazura JW; Bockarie MJ
    PLoS Negl Trop Dis; 2008; 2(12):e344. PubMed ID: 19065257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.
    Abd Elaziz KM; El-Setouhy M; Bradley MH; Ramzy RM; Weil GJ
    Am J Trop Med Hyg; 2013 Aug; 89(2):260-4. PubMed ID: 23751402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.
    Kshirsagar NA; Gogtay NJ; Garg BS; Deshmukh PR; Rajgor DD; Kadam VS; Thakur PA; Gupta A; Ingole NS; Lazdins-Helds JK
    Parasitol Res; 2017 Oct; 116(10):2683-2694. PubMed ID: 28785847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
    Lupenza ET; Gasarasi DB; Minzi OM
    PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.
    Ramzy RM; El Setouhy M; Helmy H; Ahmed ES; Abd Elaziz KM; Farid HA; Shannon WD; Weil GJ
    Lancet; 2006 Mar; 367(9515):992-9. PubMed ID: 16564361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration.
    Mayfield HJ; Sartorius B; Sheridan S; Howlett M; Martin BM; Thomsen R; Tofaeono-Pifeleti R; Viali S; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012236. PubMed ID: 38935622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endpoints for lymphatic filariasis programs.
    Grady CA; de Rochars MB; Direny AN; Orelus JN; Wendt J; Radday J; Mathieu E; Roberts JM; Streit TG; Addiss DG; Lammie PJ
    Emerg Infect Dis; 2007 Apr; 13(4):608-10. PubMed ID: 17553278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.
    Lau CL; Sheridan S; Ryan S; Roineau M; Andreosso A; Fuimaono S; Tufa J; Graves PM
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005914. PubMed ID: 28922418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
    Ramaiah KD; Vanamail P; Das PK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of microfilaremia in 'hotspots' of four lymphatic filariasis endemic districts of Nepal during post-MDA surveillance.
    Mehta PK; Maharjan M
    PLoS Negl Trop Dis; 2024 Jan; 18(1):e0011932. PubMed ID: 38295107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
    Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
    Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
    Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination within reach: A cross-sectional study highlighting the factors that contribute to persistent lymphatic filariasis in eight communities in rural Ghana.
    Minetti C; Tettevi EJ; Mechan F; Prada JM; Idun B; Biritwum NK; Osei-Atweneboana MY; Reimer LJ
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006994. PubMed ID: 30608931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.